Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Bain Capital Life Sciences Investors, LLC
Form 13F · Q2 2026

Bain Capital Life Sciences Investors, LLC

CIK 1703031申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$16.8亿
申報組合市值
21
持倉數量
12
Quarters on record
Top 50
持倉數量

Bain Capital Life Sciences Investors, LLC——持倉

共 21 個持倉中的前 21 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1KLRA Kailera Therapeutics Inc22.6M—$5.0亿29.6%
2HTFL Heartflow Inc8.4M−19.1%$2.5亿14.7%
3NAMS Newamsterdam Pharma Company3.8M−47.9%$1.3亿7.7%
4SVRA Savara Inc17.6M+0.0%$1.1亿6.4%
5ALKS Alkermes Plc1.9M+217.7%$1.0亿6.0%
6SLDB Solid Biosciences Inc9.8M+0.0%$9799万5.8%
7PHVS Pharvaris N V2.7M+0.0%$9252万5.5%
8OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc7.1M−5.2%$8864万5.3%
9COAG Hemab Therapeutics Hldgs Inc1.6M—$6060万3.6%
10CABA Cabaletta Bio Inc17.2M+78.2%$5362万3.2%
11XFOR X4 Pharmaceuticals Inc8.0M+0.0%$3721万2.2%
12DNTH Dianthus Therapeutics Inc362,470+0.0%$3533万2.1%
13CCCC C4 Therapeutics Inc7.2M+0.0%$3349万2.0%
14KYTX Kyverna Therapeutics Inc2.9M−7.2%$2571万1.5%
15ANNX Annexon Inc4.4M−14.9%$2534万1.5%
16RPID Rapid Micro Biosystems Inc8.4M+0.0%$1459万0.9%
17IRON Disc Medicine Inc141,234+0.0%$1033万0.6%
18AVIR Atea Pharmaceuticals Inc2.1M−12.1%$965万0.6%
19XLO Xilio Therapeutics Inc664,021+0.0%$636万0.4%
20UPB Upstream Bio Inc600,949−30.7%$416万0.2%
21NAMS Newamsterdam Pharma Company99,999+0.0%$214万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。